Intestinal Diseases  >>  pentamidine oral (VLX103)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pentamidine oral (VLX103) / Odan Labs
NCT01378143: Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy

Completed
2
53
Canada
OCZ103-OS [pentamidine bis(2-hydroxyethanesulfonate)], mFOLFOX6 or FOLFIRI
Oncozyme Pharma Inc.
Colorectal Cancer
03/14
07/14

Download Options